{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T06:30:36Z","timestamp":1793946636480,"version":"4.8.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100020541","name":"Royal Adelaide Hospital Research Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020541","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"NHMRC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","diabetesresearchclinicalpractice.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.diabres.2026.113235","type":"journal-article","created":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T07:59:09Z","timestamp":1775030349000},"page":"113235","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Disparities in GLP-1 and GIP responses to small intestinal glucose infusion in individuals with well- and poorly-controlled type 2 diabetes"],"prefix":"10.1016","volume":"236","author":[{"given":"Yixuan","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0054-9269","authenticated-orcid":false,"given":"Cong","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Bound","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen L.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Horowitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian A.","family":"Macdonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5116-4951","authenticated-orcid":false,"given":"Richard L.","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5527-256X","authenticated-orcid":false,"given":"Christopher K.","family":"Rayner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1656-9210","authenticated-orcid":false,"given":"Tongzhi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diabres.2026.113235_b0005","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1210\/jcem-63-2-492","article-title":"Incretin effects of increasing glucose loads in man calculated from venous insulin and C-peptide responses","volume":"63","author":"Nauck","year":"1986","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.diabres.2026.113235_b0010","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/BF02427280","article-title":"Reduced incretin effect in type 2 (non-insulin-dependent) diabetes","volume":"29","author":"Nauck","year":"1986","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabres.2026.113235_b0015","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1172\/JCI116186","article-title":"Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus","volume":"91","author":"Nauck","year":"1993","journal-title":"J Clin Invest"},{"key":"10.1016\/j.diabres.2026.113235_b0020","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/B978-0-12-381517-0.00003-5","article-title":"Dietary effects on incretin hormone secretion","volume":"84","author":"Wu","year":"2010","journal-title":"Vitamins & hormones"},{"key":"10.1016\/j.diabres.2026.113235_b0025","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1016\/S0140-6736(22)02033-5","article-title":"LY3437943, a novel triple GIP, GLP-1, and glucagon receptor agonist in people with type 2 diabetes: a phase 1b, multicentre, double-blind, placebo-controlled, randomised, multiple-ascending dose trial","volume":"400","author":"Urva","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.diabres.2026.113235_b0030","doi-asserted-by":"crossref","first-page":"3717","DOI":"10.1210\/jcem.86.8.7750","article-title":"Determinants of the impaired secretion of glucagon-like peptide-1 in type 2 diabetic patients","volume":"86","author":"Toft-Nielsen","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.diabres.2026.113235_b0035","doi-asserted-by":"crossref","first-page":"2706","DOI":"10.1210\/jc.2002-021873","article-title":"Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus","volume":"88","author":"Vilsboll","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.diabres.2026.113235_b0040","doi-asserted-by":"crossref","first-page":"678","DOI":"10.2337\/db07-1124","article-title":"Predictors of incretin concentrations in subjects with normal, impaired, and diabetic glucose tolerance","volume":"57","author":"Vollmer","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.diabres.2026.113235_b0045","doi-asserted-by":"crossref","first-page":"E550","DOI":"10.1152\/ajpendo.00326.2004","article-title":"Human duodenal enteroendocrine cells: source of both incretin peptides, GLP-1 and GIP","volume":"290","author":"Theodorakis","year":"2006","journal-title":"Am J Phys Endocrinol Metab"},{"key":"10.1016\/j.diabres.2026.113235_b0050","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s00125-010-1896-4","article-title":"Secretion of glucagon-like peptide-1 (GLP-1) in type 2 diabetes: what is up, what is down?","volume":"54","author":"Nauck","year":"2011","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabres.2026.113235_b0055","doi-asserted-by":"crossref","first-page":"E504","DOI":"10.1152\/ajpendo.00099.2005","article-title":"Initially more rapid small intestinal glucose delivery increases plasma insulin, GIP, and GLP-1 but does not improve overall glycemia in healthy subjects","volume":"289","author":"Chaikomin","year":"2005","journal-title":"Am J Phys Endocrinol Metab"},{"key":"10.1016\/j.diabres.2026.113235_b0060","doi-asserted-by":"crossref","first-page":"E743","DOI":"10.1152\/ajpendo.00159.2007","article-title":"Load-dependent effects of duodenal glucose on glycemia, gastrointestinal hormones, antropyloroduodenal motility, and energy intake in healthy men","volume":"293","author":"Pilichiewicz","year":"2007","journal-title":"Am J Phys Endocrinol Metab"},{"key":"10.1016\/j.diabres.2026.113235_b0065","doi-asserted-by":"crossref","first-page":"G1099","DOI":"10.1152\/ajpgi.00519.2006","article-title":"Concurrent duodenal manometric and impedance recording to evaluate the effects of hyoscine on motility and flow events, glucose absorption, and incretin release","volume":"292","author":"Chaikomin","year":"2007","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.diabres.2026.113235_b0070","doi-asserted-by":"crossref","first-page":"E647","DOI":"10.1152\/ajpendo.00099.2006","article-title":"The release of GLP-1 and ghrelin, but not GIP and CCK, by glucose is dependent upon the length of small intestine exposed","volume":"291","author":"Little","year":"2006","journal-title":"Am J Phys Endocrinol Metab"},{"key":"10.1016\/j.diabres.2026.113235_b0075","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.metabol.2015.10.025","article-title":"Abundance and turnover of GLP-1 producing L-cells in ileal mucosa are not different in patients with and without type 2 diabetes","volume":"65","author":"Kampmann","year":"2016","journal-title":"Metabolism"},{"key":"10.1016\/j.diabres.2026.113235_b0080","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1007\/s00125-017-4450-9","article-title":"Enteroendocrine K and L cells in healthy and type 2 diabetic individuals","volume":"61","author":"Jorsal","year":"2018","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabres.2026.113235_b0085","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1172\/JCI118411","article-title":"Gastric emptying and release of incretin hormones after glucose ingestion in humans","volume":"97","author":"Schirra","year":"1996","journal-title":"J Clin Investig"},{"key":"10.1016\/j.diabres.2026.113235_b0090","doi-asserted-by":"crossref","first-page":"3431","DOI":"10.1210\/jc.2004-0334","article-title":"Effect of variations in small intestinal glucose delivery on plasma glucose, insulin, and incretin hormones in healthy subjects and type 2 diabetes","volume":"89","author":"O'Donovan","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.diabres.2026.113235_b0095","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1007\/BF00400362","article-title":"Relationship between oral glucose tolerance and gastric emptying in normal healthy subjects","volume":"36","author":"Horowitz","year":"1993","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabres.2026.113235_b0100","doi-asserted-by":"crossref","DOI":"10.1007\/BF00186645","article-title":"Relationships between oesophageal transit and solid and liquid gastric emptying in diabetes mellitus","volume":"18","author":"Horowitz","year":"1991","journal-title":"Eur J Nucl Med"},{"key":"10.1016\/j.diabres.2026.113235_b0105","doi-asserted-by":"crossref","first-page":"468","DOI":"10.2337\/diacare.19.5.468","article-title":"Rapid gastric emptying of a solid pancake meal in type II diabetic patients","volume":"19","author":"Schwartz","year":"1996","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2026.113235_b0110","doi-asserted-by":"crossref","first-page":"3311","DOI":"10.1210\/jc.2018-02736","article-title":"Gastric emptying in patients with well-controlled type 2 diabetes compared with young and older control subjects without diabetes","volume":"104","author":"Watson","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.diabres.2026.113235_b0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2020.108610","article-title":"Gastric emptying in health and type 2 diabetes: an evaluation using a 75 g oral glucose drink","volume":"171","author":"Xie","year":"2021","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.diabres.2026.113235_b0120","doi-asserted-by":"crossref","first-page":"3078","DOI":"10.1111\/dom.15626","article-title":"Gastric emptying in newly diagnosed, treatment-naive Han chinese with type 2 diabetes and the impact of 4-week insulin pump therapy","volume":"26","author":"Sun","year":"2024","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.diabres.2026.113235_b0125","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/BF00265086","article-title":"Gastric and oesophageal emptying in patients with type 2 (non-insulin-dependent) diabetes mellitus","volume":"32","author":"Horowitz","year":"1989","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabres.2026.113235_b0130","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1111\/j.1464-5491.2011.03496.x","article-title":"Effects of variations in duodenal glucose load on glycaemic, insulin, and incretin responses in type 2 diabetes","volume":"29","author":"Ma","year":"2012","journal-title":"Diabet Med"},{"key":"10.1016\/j.diabres.2026.113235_b0135","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1007\/BF00403919","article-title":"The effect of acute hyperglycaemia on small intestinal motility in normal subjects","volume":"39","author":"Russo","year":"1996","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabres.2026.113235_b0140","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1210\/jc.2008-2197","article-title":"Hyperglycemia acutely lowers the postprandial excursions of glucagon-like Peptide-1 and gastric inhibitory polypeptide in humans","volume":"94","author":"Vollmer","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.diabres.2026.113235_b0145","doi-asserted-by":"crossref","first-page":"3532","DOI":"10.2337\/db13-0581","article-title":"Disordered control of intestinal sweet taste receptor expression and glucose absorption in type 2 diabetes","volume":"62","author":"Young","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.diabres.2026.113235_b0150","doi-asserted-by":"crossref","first-page":"308","DOI":"10.7326\/0003-4819-92-2-308","article-title":"Assessment of cardiovascular effects in diabetic autonomic neuropathy and prognostic implications","volume":"92","author":"Ewing","year":"1980","journal-title":"Annual internal med"},{"key":"10.1016\/j.diabres.2026.113235_b0155","doi-asserted-by":"crossref","first-page":"R1524","DOI":"10.1152\/ajpregu.00378.2010","article-title":"Effects of small intestinal glucose load on blood pressure, splanchnic blood flow, glycemia, and GLP-1 release in healthy older subjects","volume":"300","author":"Vanis","year":"2011","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.diabres.2026.113235_b0160","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1097\/CCM.0b013e31820ee21f","article-title":"Glucose absorption and small intestinal transit in critical illness","volume":"39","author":"Deane","year":"2011","journal-title":"Critical care med"},{"key":"10.1016\/j.diabres.2026.113235_b0165","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1007\/s00125-007-0819-5","article-title":"Within-subject variability of measures of beta cell function derived from a 2 h OGTT: implications for research studies","volume":"50","author":"Utzschneider","year":"2007","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabres.2026.113235_b0170","first-page":"357","article-title":"Gastric emptying is accelerated in obese type 2 diabetic patients without autonomic neuropathy","volume":"27","author":"Bertin","year":"2001","journal-title":"Diabetes and metabolism"},{"key":"10.1016\/j.diabres.2026.113235_b0175","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.2337\/db06-1033","article-title":"Downregulation of GLP-1 and GIP receptor expression by hyperglycemia: possible contribution to impaired incretin effects in diabetes","volume":"56","author":"Xu","year":"2007","journal-title":"Diabetes"},{"key":"10.1016\/j.diabres.2026.113235_b0180","doi-asserted-by":"crossref","first-page":"3346","DOI":"10.2337\/dc13-0465","article-title":"Secretion of glucose-dependent insulinotropic polypeptide in patients with type 2 diabetes: systematic review and meta-analysis of clinical studies","volume":"36","author":"Calanna","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2026.113235_b0185","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.2337\/db08-0958","article-title":"Exogenous glucose-dependent insulinotropic polypeptide worsens post prandial hyperglycemia in type 2 diabetes","volume":"58","author":"Chia","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.diabres.2026.113235_b0190","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1111\/j.1464-5491.2008.02579.x","article-title":"Four weeks of near-normalization of blood glucose has no effect on postprandial GLP-1 and GIP secretion, but augments pancreatic B-cell responsiveness to a meal in patients with type 2 diabetes","volume":"25","author":"Hojberg","year":"2008","journal-title":"Diabet Med"},{"key":"10.1016\/j.diabres.2026.113235_b0195","doi-asserted-by":"crossref","first-page":"6201","DOI":"10.1210\/jc.2019-01262","article-title":"Longitudinal changes in fasting and glucose-stimulated GLP-1 and GIP in healthy older subjects","volume":"104","author":"Pham","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.diabres.2026.113235_b0200","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1210\/jc.2011-2583","article-title":"Comparative effects of variations in duodenal glucose load on glycemic, insulinemic, and incretin responses in healthy young and older subjects","volume":"97","author":"Trahair","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.diabres.2026.113235_b0205","doi-asserted-by":"crossref","first-page":"e712","DOI":"10.1210\/clinem\/dgad176","article-title":"Disparities in the glycemic and incretin responses to intraduodenal glucose infusion between healthy young men and women","volume":"108","author":"Xie","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.diabres.2026.113235_b0210","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1055\/s-2005-861160","article-title":"Nutrient-stimulated GLP-1 release in normal-weight men and women","volume":"37","author":"Adam","year":"2005","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.diabres.2026.113235_b0215","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.2337\/db14-1751","article-title":"GLP-1 response to oral glucose is reduced in prediabetes, screen-detected type 2 diabetes, and obesity and influenced by sex: the addition-pro study","volume":"64","author":"F\u00e6rch","year":"2015","journal-title":"Diabetes"},{"key":"10.1016\/j.diabres.2026.113235_b0220","doi-asserted-by":"crossref","first-page":"865","DOI":"10.3945\/ajcn.117.154377","article-title":"Effects of randomized whey-protein loads on energy intake, appetite, gastric emptying, and plasma gut-hormone concentrations in older men and women","volume":"106","author":"Giezenaar","year":"2017","journal-title":"Am J Clin Nutr"}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822726001543?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822726001543?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T05:57:55Z","timestamp":1793944675000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168822726001543"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":44,"alternative-id":["S0168822726001543"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2026.113235","relation":{},"ISSN":["0168-8227"],"issn-type":[{"value":"0168-8227","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Disparities in GLP-1 and GIP responses to small intestinal glucose infusion in individuals with well- and poorly-controlled type 2 diabetes","name":"articletitle","label":"Article Title"},{"value":"Diabetes Research and Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabres.2026.113235","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"113235"}}